Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.21.2
Condensed Statements of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Cash flows from operating activities:          
Net loss     $ (19,541,592) $ (16,802,402)  
Adjustments to reconcile net loss to Net cash used in operating activities:          
Depreciation and amortization     126,385 217,629  
Stock based compensation $ 4,228,324 $ 2,069,907 6,374,550 4,346,206  
Changes in operating lease right-of-use assets     393,936 378,593  
Bad debt expense       33,000  
Changes in operating assets and liabilities:          
Accounts receivable     (46,120) (75,082)  
Prepaid expenses and other current assets     (10,769) (212,727)  
Accounts payable     555,702 (330,537)  
Accrued expenses     31,251 (429,460)  
Operating lease liabilities     (422,533) (341,064)  
Deferred revenue     1,500    
Net cash used in operating activities     (12,537,690) (13,215,844)  
Cash flows from investing activities:          
Purchases of property and equipment     (203,004)    
Net cash used in investing activities     (203,004)    
Cash flows from financing activities:          
Net proceeds from the sales of common stock       14,723,491 $ 53,556,202
Proceeds from contributions to employee stock purchase plan     237,247 217,204  
Net cash provided by financing activities     237,247 14,940,695  
Net (decrease) increase in cash and cash equivalents     (12,503,447) 1,724,851  
Cash and cash equivalents - beginning     50,729,661 21,684,089 21,684,089
Cash and cash equivalents - ending $ 38,226,214 $ 23,408,940 38,226,214 23,408,940 $ 50,729,661
Restricted Stock Units (RSUs) [Member]          
Supplemental disclosure of non-cash financing activities:          
Common stock issued     9 $ 6  
Performance Shares [Member]          
Supplemental disclosure of non-cash financing activities:          
Common stock issued     $ 5